Introduction
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease affecting approximately 1-2% of the population worldwide [1] . The disease is characterized by immunological dysfunction and chronic inflammation which result in synovial joint deformity and destruction [1] . RA is thought to develop as a result of environmental insults to genetically susceptible individuals. The heritable component of RA has been estimated at 50-60% with HLA-DRB4 [2] and PTPN22 identified as the predominant genetic markers [3] . Putative environmental factors which have been associated with disease onset, include viral infection (e.g. parvovirus B19) and gut bacteria (e.g. Proteus mirabilis) [4] , smoking [5] , and dietary components including antioxidants [6] .
In addition to RA, other rheumatic diseases in which autoimmunity is an important pathogenetic feature include systemic lupus erythematosus (SLE) (see also the article in this Special Issue by Helen Wright and coworkers, pp. 25-35), Sjögren's syndrome, and scleroderma (systemic sclerosis) (see also the article in this Special Issue by Armando Gabrielli and coworkers, pp. [90] [91] [92] [93] [94] [95] [96] [97] . These systemic autoimmune diseases share clinical, immunological, and genetic features but have disease-specific traits [7] . In SLE patients, almost any organ of the body could be a target for autoimmune inflammation, whereas Sjögren's syndrome often affects exocrine glands; in scleroderma the skin is invariably affected. In SLE, more than twenty five genes contribute to the mechanisms that predispose individuals to the disease [8] . The deposition of immune complexes in the glomeruli of the kidney causes inflammation and leads to tissue damage [9] . Sjögren's syndrome causes secretory gland dysfunction, leading to dryness of the main mucosal surfaces such as the mouth and eyes along with abnormal fatigue [10] . Finally, systemic sclerosis is a disease which characteristically has two components to its pathology: fibrosis and microvascular disease. Fibrosis commonly involves the skin and internal organs especially the lung, and vascular changes are evident peripherally and in the pulmonary circulation [11, 12] .
A common feature of the above autoimmune diseases is the increased production of reactive oxygen species (ROS) and reactive nitrogen species (RNS) in association with an inflammatory response. ROS are produced by host phagocytes and exert antimicrobial actions against a broad range of pathogens. Thus, ROS generation is a physiological defense against microbial infection, but the inappropriate generation of ROS, as occurs in autoimmune inflammation, causes tissue damage. Such damage is the result of the chemical reactivity of certain ROS with biomolecules, such as DNA, lipids, carbohydrates and proteins. Key ROS, RNS, reactive sulfur species (RSS) and reactive chlorine species (RCS) present in inflamed joints are the superoxide anion radical (Ο 2 ⋅− ), hydrogen peroxide (H 2 O 2 ), hydroxyl radical (
• OH), hypochlorous acid (HOCl), nitric oxide (NO), peroxynitrite (ONOO − ), lipid peroxides, and hydrogen sulfide (H 2 S), which are involved in acute and chronic inflammation [13, 14] . Chemically modified biomolecules representing the products of the reactions of ROS/ RNS/RSS/RCS have been identified in knee-joint tissue/fluid samples collected from patients with RA [15] [16] [17] [18] .
The involvement of post-translational modifications to proteins in the pathogenesis of a range of human autoimmune diseases is receiving increasing research interest, stimulated in part by the discovery that one particular post-translational modification of proteins, citrullination, is associated with antigenicity in RA patients [19] . Citrullinated proteins are recognized by serum autoantibodies in RA patients, and nowadays the measurement of such autoantibodies forms the basis of one of the main clinical diagnostic tests for RA (see section 4.2.1 below). There is mounting evidence that other protein modifications, including oxidative post-translational protein modifications, may also play key roles in human systemic autoimmune diseases. In the present review, we will discuss the current evidence for a role of oxidative protein modifications in the pathogenesis of a group of human autoimmune diseases and syndromes, which include RA, SLE, Sjögren's syndrome and systemic sclerosis (scleroderma). In order to provide an overview of this research area, we will first discuss the sources of reactive oxygen species (ROS) in inflammatory autoimmune conditions. We will also describe the enzymes and small molecule antioxidants that maintain physiological redox homeostasis in the presence of ROS-generating systems, and the perturbations of this "pro-oxidant/antioxidant" system that occur in inflammatory autoimmune diseases. Consideration of the above pathophysiological events provides insight, not only into potential therapeutic strategies in this disease area, but also novel diagnostic assays -which will be described.
2. Sources of reactive oxygen, nitrogen, sulfur and chlorine species in inflammation
NADPH oxidases
As part of the innate immune system, neutrophils are a crucial component in the first line of defense against invading microorganisms. A number of processes -that include phagocytosis, generation of ROS via the respiratory burst, and the release of microbicidal substances from cytoplasmic granules -help in the elimination of microbes. In addition, a process characterized by the formation of neutrophil extracellular traps (NETs) [20] 
In biological systems,
• OH production arises from the transition metal ion-catalyzed Haber-Weiss reaction [22] (Eq. (2)):
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which involves the reaction of reduced transition metal ions in a Fenton-type reaction [23] (Eq. (3)).
The hydroxyl radical is a highly potent oxidant reacting rapidly with virtually all biomolecules. Hydrogen peroxide also reacts with chloride ions (Cl − ) to generate HOCl (reaction 4), in a reaction catalyzed by the enzyme myelopeoxidase (MPO) [24, 25] (Eq. (4)):
A number of isoforms of NOX (NOXs 1-5 as well as DUOXs 1 and 2) have been identified, all having distinct catalytic domains [26] . The most widely characterized NADPH oxidase is phagocytic NOX2 (gp91phox), which is a multi-subunit enzyme complex with both plasma membrane and cytosolic components [27] . Other isoforms reside in different specialized tissues and different intracellular loci. NOX4 is the only member of the family to have a mitochondrial localization [28] . NOX4 differs from the other members of the NOX family in that it preferentially catalyzes the production of H 2 O 2 rather than O 2 ·− [29] .
The NOXs catalyze the generation of Ο 2 ⋅− (and H 2 O 2 ) [30] and are attractive for the development of isozyme-specific inhibitors [31, 32] . In experimental models, diphenyl iodonium and apocynin have been shown to inhibit phorbol myristate acetate-induced Ο 2 ⋅− production in a concentration-dependent manner in the fibroblast-like cells from RA knee-joint synovial tissue, whereas specific inhibitors of other oxidases (lipoxygenase, cyclooxygenase and xanthine oxidase) showed no effect [33] . Hydroxychloroquine, a drug commonly used in the treatment of SLE and RA, prevented the induction of endosomal NOX2 assembly, thereby decreasing the action of NOX2 [34] . However, NOX2-deficient mice develop markedly exacerbated lupus, suggesting that failure to undergo normal NOX2-dependent cell death may result in lupus pathogenesis [35] . Unexpectedly, the failure to undergo normal NOX-2-dependent cell death may result in release of immunogenic self-constituents that stimulate lupus [35] . Additionally, NOX2 activity is also required for the form of neutrophil cell death termed "NETosis", releasing neutrophil extracellular traps [36] . Neutrophil cytosolic factor 1 (Ncf1) is a key regulatory component of the ROS-generating phagocytic NOX2 complex. Polymorphisms of the NCF1 gene (associated with Ncf1 deficiency) have been associated with increased arthritis severity and predispose both humans and rodents to autoimmunity [37] (see also the article in this Special Issue by Rikard Holmdahl and coworkers, pp. 72-80). However, it has recently been found that in targeted NCF1 knock-in mice with inducible Ncf1 expression, NOX2-derived ROS protect mice from arthritis. This observation points to a regulatory role of NOX2-derived ROS in collageninduced arthritis in mice [38] .
One of the most advanced NADPH oxidase inhibitors, in terms of drug development stage, is GKT-831 (formerly GKT137831), belonging to a structural class of pyrazolopyridine diones. This compound is a dual inhibitor of isoforms NOX4 and NOX1 [39] . Recently, clinical trials demonstrated that inhibition of NOX1 and/or NOX4 may provide a safe yet broadly effective therapeutic approach in a range of inflammatory and fibrotic disorders including scleroderma [40] .
MPO plays an important role in intracellular pathogen killing, but when it is released extracellularly after neutrophil activation, it causes tissue damage at inflammatory sites, as demonstrated in patients with autoimmune inflammatory conditions, including RA [25] , SLE [41] , Sjögren's syndrome [42] and scleroderma [43] . MPO constitutes a potential therapeutic target, leading to interest in the design of MPO inhibitors for the treatment of these inflammatory diseases. However, MPO inhibits the generation of adaptive immune responses by attenuating T cell-driven tissue inflammation and limiting pathological tissue inflammation [44] . Therefore it is unclear whether inhibition of MPO would be beneficial in autoimmune rheumatic diseases. Inhibitors of MPO, including the 2-thioxanthines, have been developed and shown to limit oxidative stress at sites of inflammation [45] .
Mitochondrial respiratory chain
In the case of mitochondrial electron transport, the transfer of protons across the inner membrane creates an electrochemical proton gradient, which facilitates the conversion of ADP to ATP during oxidative phosphorylation [46] . Mitochondrial metabolism results in the buildup of potentially damaging levels of ROS, due to the leakage of electrons from the electron transport chain. The mitochondrial permeability transition pore (mPTP) opens and allows ROS to leave the mitochondria, preventing the accumulation of toxic levels of ROS within the mitochondria. At higher ROS levels, longer durations of mPTP opening may release a ROS burst leading to the destruction of mitochondria, and, if propagated from mitochondrion to mitochondrion, of the cell itself [47] .
Mitochondrial dysfunction has been suggested to induce an inflammatory response in normal human synoviocytes and to sensitize these cells, causing a significant amplification of the inflammatory response induced by interleukin-1β [48] . Mitochondrial dysfunction and abnormal oxygen metabolism appear to play a role in the immunopathogenesis of SLE [49] . The sustained elevation of mitochondrial ROS may play an important role in cell death by apoptosis and necrosis of SLE lymphocytes, and may account for the lymphopenia, as well as the intensification of the inflammatory cascade, in these patients [50] . In relation to RA, there was a five-fold increase in mitochondrial ROS production in whole blood and monocytes from patients with RA, when compared to healthy subjects or patients with non-rheumatic diseases [51] . In addition to increased oxidative stress in SLE, there may well be an increased susceptibility to oxidative damage because of mitochondrial dysfunction and glutathione depletion [52] .
Nitric oxide synthases
The human NO synthase (NOS) isoenzyme family consists of neuronal NOS (nNOS, NOS1), inducible NOS (iNOS, NOS2), and endothelial NOS (eNOS, NOS3). These enzymes catalyze the generation of nitric oxide (NO), using L-arginine, oxygen and NADPH as substrates (reaction 5). NO is important not only in physiological processes such as apoptosis, salutary inflammation, mitochondrial biogenesis and the regulation of blood vessel tone [53, 54] , but also in many inflammatory diseases, including RA [55, 56] , SLE [57] , Sjögren's syndrome [58] and scleroderma [59] . In RA, the production of NO catalyzed by iNOS is increased in macrophages by the pro-inflammatory cytokines IL-1, tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ). NO reacts rapidly with Ο 2 ⋅− producing the potent oxidant, peroxynitrite (ONOO − ) [60] which, in turn, causes biomolecular damage such as protein nitration in RA [61] . In blood, where oxyhemoglobin is present within red blood cells, NO is oxidized to nitrite (NO 2 -) and nitrate (NO 3 -). For this reason, NO 3 -and NO 2 -are often employed as markers of NO production in biological samples, the assumption being that NO 3 - and NO 2 -are inert end-products of NO oxidation (but see the discussion in the next sub-section).
It is established that increased levels of S-nitrosothiols are present in RA plasma and in knee-joint synovial fluid, and S-nitrosothiol concentrations are correlated with measures of inflammation in RA. This confirms increased NO generation at the site of disease pathology but also suggests that S-nitrosothiol concentrations could potentially be used to monitor disease activity in RA [62] . The increased NO production in RA can also be detected by examining urinary NO 3 -excretion, expressed as urinary NO 3 -: creatinine ratios; one study found a significantly elevated ratio in patients suffering from RA, with a threefold elevation over healthy controls [63] . Successful treatment of inflammation would be expected to lower NO generation. In patients with severe RA, anti-TNFα therapy (using Infliximab) was shown to decrease serum NO concentrations -as predicted, given that TNF-α increases the expression of iNOS in macrophages and vascular endothelial cells [64] .
There is very little literature regarding the role of oxidative stress in Sjögren's syndrome. One study suggested decreased concentrations of NO 2 -and NO 3 -in the saliva, but simultaneously there was also increased urinary NO 3 -secretion [65] . However, another study found increased NO 2 -concentrations in labial salivary gland biopsy specimens [66] . Salivary gland hypofunction probably disrupts the enterosalivary pathway of nitrate metabolism, but the exact process is currently unclear (see below for a more detailed discussion of the enterosalivary circulation of nitrate).
There is a wealth of evidence to implicate the overproduction of ROS in the pathogenesis of SLE as a consequence of a maladaptive innate immune system. Measures of oxidative stress can be correlated with disease activity in both cross-sectional and longitudinal studies [57, 67] . Moreover, iNOS inhibitors reduce markers of damage and oxidative stress in animal models of lupus nephritis [68] . Higher NO levels are associated with an accumulation of renal damage and a lack of response to therapy [69] . In 1993, Murrell [70] suggested testing 'free radical scavengers' in scleroderma and, since then, evidence has accumulated to implicate excessive oxidative stress in fibroblast activation and microvascular damage. Animal models of scleroderma confirmed abnormal NO metabolism and reduced activity of cytoprotective antioxidants [71] . ROS-induced protein and lipid damage, in addition to DNA damage, can be demonstrated and correlated to clinical features of disease and disease severity, such as the presence of lung fibrosis and modified Rodnan score [72, 73] .
NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) is a transcription factor which regulates the expression of many genes involved in immune and inflammatory responses [74] . NF-κB is activated by pro-inflammatory cytokines such as IL-1 and TNF-α. Products of the genes that are regulated by NF-κB also cause the activation of NF-κB. For example, IL-1 and TNF-α both activate, and are activated by, NF-κB. This type of positive regulatory loop may amplify and perpetuate the local inflammatory responses. NF-κB activation has been shown to be involved in the increased expression of iNOS [75] . In RA, elevated activation of NF-κB has been detected in the type A synoviocytes and endothelial cells of knee-joint synovial tissue [76] . NF-κB exhibited continuous high activation in synovial tissue from RA patients compared with osteoarthritis (OA) and normal synovial tissue [77] .
As NF-κB activation is elevated in several chronic inflammatory diseases, much attention has focused on the development of anti-inflammatory drugs targeting NF-κB [78] . Glucocorticoids are effective inhibitors of NF-κB [79] , but steroids have endocrine and metabolic side effects when given systemically. Several lines of evidence indicate that ROS serve as second messengers in the activation pathway of NF-κB [80] and N-acetyl-L-cysteine, an antioxidant, prevented the activation of NF-kappa B by H 2 O 2 [81] .
Nitrite reductase
Green leafy vegetables and beetroot juice are dietary sources of nitrate (NO 3 -), which can be converted to NO 2 -by commensal bacteria on the surface of the human tongue. NO 2 -is then swallowed and absorbed into the circulation [82, 83] . The reduction of NO 2 -to NO is catalyzed by human xanthine oxidase (XO) (Eq. (6)) [84] .
Electrons for this XO-catalyzed NO generation can be donated by the substrates NADH or xanthine. In vivo, NO 2 -has a role in blood vessel dilation [85] and in oxygen sparing during exercise [86] especially under hypoxic conditions. NO 2 − also modulates cellular respiration [87] and is cytoprotective against ischemia-reperfusion injury [88] . NO 2 -exerts cytoprotective activities in the stomach, where it protects the tissues against gastric ulcers induced by aspirin-like drugs (nonsteroidal anti-inflammatory drugs; NSAIDS) [83] . In general, the above properties of NO 2 -have been attributed to endogenous biochemical reactions by which NO 2 -is reduced to NO which, in turn, exerts biological activity. In addition to XO [84] , several other mechanisms and enzymes have been identified as possible NO 2 -reductases in humans:
deoxyhemoglobin [85] , myoglobin [87] , eNOS under hypoxic conditions [89] and the mitochondrial respiratory chain [90, 91] . Additionally, NO 2 -is chemically reduced to NO at low pH in the stomach [92] . In mammals, xanthine oxidoreductase is present in vivo in two interconvertible forms: xanthine dehydrogenase and XO. The inflamed rheumatoid joint is subject to intermittent cycles of hypoxia and reperfusion [93] . During hypoxia (see also the article in this Special Issue by Ursula Fearon and coworkers, pp. 15-24), xanthine dehydrogenase is converted to XO and the affinity for oxygen is significantly enhanced, resulting in univalent and divalent electron transfer to O 2 , generating Ο 2 ⋅− and H 2 O 2 , respectively. The production rates of these two ROS depend on O 2 tension, pH and purine concentration, the formation of H 2 O 2 being favored when O 2 levels and pH are low as under hypoxic conditions. The inflamed RA joint is often chronically hypoxic and acidotic [93] , conditions which might promote the reduction of NO 2 -to NO. Interestingly, we observed [84] that NO generation by synovial tissue from RA joints, after the addition of NO 2 -, was inhibited by the XO inhibitor allopurinol but not by the non-specific NOS inhibitor, Nω-nitro-L-arginine (L-NNA). However, the role of the nitrate-nitrite-NO reduction pathway, if any, in NO generation at sites of inflammation remains unclear.
2.5. Cystathionine-β synthase, cystathionine-γ lyase and 3-mercaptopyruvate sulfotransferase
Hydrogen sulfide (H 2 S) appears to function as a physiological gaseous mediator in human tissues and low levels of H 2 S are neuroprotective, cardioprotective, anti-apoptotic and anti-inflammatory [94] . H 2 S is generated by mammalian cells in reactions catalyzed by three distinct enzymes: cystathionine-β synthase (CBS), cystathionine-γ lyase (CSE) and 3-mercaptopyruvate sulfotransferase (3MST) from the amino acid substrates L-cysteine, L-homocysteine and L-cystathionine [94, 95] , as shown in Fig. 1 .
Although the exact cellular concentrations of H 2 S remain unknown, they are most likely in the nM range. In addition to free H 2 S, acid-labile and protein-bound sulfane sulfur pools exist [96] . H 2 S has been shown to be protective against a variety of oxidative stress-related injuries and ROS-induced toxicity [97] and H 2 S regulates a growing list of physiological functions, such as blood pressure, cell-signaling, pain and inflammation [98] . H 2 S has multiple physiological roles and at higher concentrations has pathophysiological roles, linking it to human diseases [99] . This biphasic effect of H 2 S on inflammatory signaling was observed in LPS-treated murine macrophages, where low concentrations of H 2 S inhibited LPS-induced synthesis of PGE 2 , NO, IL-1β, IL-6 and NF-κB activity, but higher concentrations of H 2 S promoted the synthesis of pro-inflammatory mediators [100] . In relation to the inflammatory response, H 2 S synthesis catalyzed by CBS and CSE is upregulated by LPS and inflammatory cytokines (e.g. TNF-α). Indeed, H 2 S was found to be present in inflammatory synovial fluid, and levels correlated with inflammatory and clinical indices in RA patients [101] . Furthermore, H 2 S has a number of functions in common with another gaseous mediator, NO, and the two gases are thought to exhibit biological cross-talk (Fig. 2) [102] . H 2 S has been shown to be a pro-inflammatory mediator in various animal models of shock, edema, chronic inflammation, and acute inflammation [103] [104] [105] [106] and has also been shown to inhibit the abnormal activation of lymphocytes from SLE patients [107] .
Removal of reactive nitrogen and oxygen species
Small molecule antioxidant compounds such as vitamin C (ascorbic acid), vitamin E (α-tocopherol), β-carotene and glutathione provide protection against biomolecular damage associated with oxidative stress [1] by chemically "scavenging" ROS. An antioxidant has been defined as any substance that, when present at lower concentrations than those of an oxidizable substrate, delays oxidation of that substrate [108] . In addition, a number of antioxidant enzymes play crucial roles in regulating ROS concentrations, under conditions of cellular oxidative stress as well as cellular redox signaling. Key antioxidant enzymes are described below.
Superoxide dismutase, catalase, and glutathione peroxidase
Three human superoxide dismutase (SOD) isozymes are known: SOD1 (copper/zinc SOD) in the cytosol, SOD2 (manganese SOD) in the mitochondria, and SOD3 (an extracellular copper-containing SOD) [109] . In mammals these SOD enzymes catalyze the conversion of O 2 .-to H 2 O 2 (Eq. (2)) [110] . Hydrogen peroxide is further chemically reduced to H 2 O in the presence of catalase, glutathione (GSH) reductase and GSH peroxidase (Eqs. (7)- (9) 
Glutathione (GSH) is an antioxidant tripeptide consisting of glutamic acid, cysteine, and glycine. GSH is the most abundant low-molecular-weight thiol-containing compound in biological fluids and tissues of mammals, with an intracellular concentration estimated to range from 0.5 to 10 mM [111] . The thiol group of the cysteine residue in GSH allows GSH to serve as a substrate for glutathione peroxidase (GPx) [108] (Eq. (8) ). Eight different isoforms of glutathione peroxidase (GPxs 1-8) have been identified in humans, including GPx-1 in the cellular cytosol and GPx-4 in the mitochondria. GPxs catalyze the chemical reduction of H 2 O 2 to water in the presence of glutathione (GSH) which is oxidized to glutathione disulfide (GSSG) in the process. Glutathione reductase (GSHR) catalyzes the reduction of GSSG to GSH using NADPH as an electron donor (Eq. (9)), thus replenishing the GSH pool. The ratio of GSH/GSSG is often used as a biomarker of oxidative stress [112] . SLE patients exhibited significantly lower levels of SOD and catalase in neutrophils/lymphocytes compared to healthy individuals [113] . Moreover, levels of GPx-1/GPx-4 were decreased in neutrophils/lymphocytes of SLE and RA patients [114, 115] . SLE patients were found to have a decreased GSH and GSH/GSSG ratio which correlated with the disease activity index and extent of organ damage [114, 115] . Based on these data, it has been suggested that increasing GSH levels through supplementation of N-acetylcysteine could be a feasible therapeutic strategy [116] .
Peroxiredoxins, thioredoxins and thioredoxin reductases
Peroxiredoxins (Prxs), also known as thioredoxin peroxidases, are an ubiquitous family of antioxidant enzymes, which catalyze the reduction of peroxides, such as H 2 O 2 , using cysteine-containing active sites [117] . Prxs have molecular weights in the 22-27 kDa region, and are non-seleno and non-haem peroxidases. The Prx family consists of six isozymes, Prx1-6, in the case of mammalian systems [118] . These proteins contain either one (1-Cys Prx) or two (2-Cys Prx) redox-active cysteine residues [119, 120] . The 2-Cys group includes Prx1 to Prx5, whereas Prx6 is the sole member of the 1-Cys group [121, 122] . The physiological importance of Prxs is illustrated by their relative abundance. Thioredoxins (Trxs) are ubiquitous proteins and are major hydrogen donors in many biological redox reactions [123] . The main function of Trxs is to keep protein thiols in the reduced state. For this reason, Trx is often regarded as an antioxidant enzyme. Thioredoxin reductase (TrxR) is a selenoenzyme with three isoforms, TrxRs 1-3. TrxR1 is a cytosolic and extracellular enzyme whereas TrxR2 is localized to mitochondria [124] . TrxR is the only enzyme known to catalyze the reduction of Trx [125] . Electrons are taken from NADPH via TrxR and are transferred to the active site of Trx, which goes on to reduce protein disulfides or other substrates [126] . TrxR1 was found to be upregulated in primary RA synovial fibroblasts compared to osteoarthritis synovial fibroblasts and prevented cell death by suppressing H 2 O 2 levels [127] . Prxs are important regulators of inflammatory diseases and Prx6 was shown to cause the exacerbation of collagen antibody-induced arthritis in transgenic mice overexpressing Prx6 [128] . Another study showed that the level of intracellular Prx2 in lymphocytes from RA patients was more than 2-fold higher compared with healthy lymphocytes, suggesting that Prx2 might be involved in the persistence of pro-inflammatory cells in chronic inflammation [129] .
In autoimmune inflammatory diseases, such as RA, excessive ROS/ RNS arise from the activation of NOX2 and iNOS which may modulate inflammation-related cell signaling pathways. The antioxidant pathway is controlled by the transcription factor nuclear factor (erythroid-derived 2)-like 2 (Nrf2). Nrf2 is involved in regulating the expression of about 1% of human genes, which contain in their promoter regulatory regions an enhancer sequence termed the Antioxidant Response Element (ARE) [130] . Kelch-like ECH associated protein 1 (Keap1) controls the expression of Nrf2, whereby Keap1 loses this function in response to oxidants which chemically modify reactive cysteine sensors in Keap1 [131] disrupting its ability to target Nrf2 for ubiquitination and degradation so that newly synthesized Nrf2 is stabilized to activate target-gene transcription. There is a wealth of experimental evidence that the Keap1-Nrf2 pathway lies at the heart of cellular defense, playing crucial roles in adaptation and survival [132] . Nrf2 is now considered a drug target for various diseases in which oxidative stress and inflammation underlie the disease pathogenesis [133] . Nrf2 activators have been identified that appear to disrupt the Keap1/Nrf2 interaction, such as dimethyl fumarate in the treatment of discoid SLE [134] .
Nrf2 directly regulates the gene expression of the catalytic and the regulatory subunits of γ-glutamyl cysteine ligase (GCL), the enzyme catalyzing the rate-limiting step in the biosynthesis of GSH [135] . Additionally, cysteine serves as a precursor for the biosynthesis of GSH Fig. 2 . Schematic summary of the key features of NO and H 2 S generation and metabolism. These two gaseous transmitters have features in common such as their endogenous enzyme-catalyzed generation, as well as the involvement of free thiols (e.g. cysteine residues within proteins) in the formation of products of the reactions of both gases (NO and H 2 S). Cofactors for these enzymes are reduced nicotinamide-adenine-dinucleotide phosphate (NADPH), flavin adenine dinucleotide (FAD), flavin mononucleotide (FMN), and (6R-)5,6,7,8-tetrahydrobiopterin (BH4). Enzymes involved in hydrogen sulfide synthesis include cystathionine-β synthase (CBS) and cystathionine-γ lyase (CSE). Enzymes involved in nitric oxide synthesis include neuronal NOS (nNOS, NOS1), inducible NOS (iNOS, NOS2) and endothelial NOS (eNOS, NOS3). Both gases are involved in the regulation of blood pressure, inflammation, redox signaling, learning and memory. [136] . Glutathione reductase, which catalyzes the biochemical reduction of GSSG, thus maintaining the levels of GSH, is also transcriptionally regulated by Nrf2 [137] . Cells deficient in Nrf2 have lower levels of GSH, whereas Nrf2 activation leads to GSH upregulation [138] . As GSH is the principal small molecule antioxidant in the cell, the levels of ROS are increased under conditions of Nrf2 deficiency [139] . In addition Nrf2 controls the expression of the proteins responsible for the lowering of oxidized protein thiols, namely Trx [140] and TrxR1 [141] . Nrf2 deficient mice were observed to have an increased inflammatory response, supporting a protective role for Nrf2 against joint inflammation and degeneration in arthritis, and supporting the concept that Nrf2 may be a therapeutic target for arthritis [142] .
There is also an emerging role of the Keap1-Nrf2 pathway in bioenergetics, in relation to maintaining mitochondrial homeostasis. Nrf2 deficiency causes a decrease in membrane potential due to inhibition of mitochondrial respiration that leads to increased ROS production [143] .
Consequences of an imbalance between ROS production and removal
Oxidative or nitrative stress arises when the production of ROS/RNS exceeds their removal by scavenger systems, resulting in the accumulation of end-products of the reactions of these agents with biomolecules [144] . Oxidative stress occurs during inflammation and causes proteins to become damaged by reactive species such as reactive oxygen, nitrogen, sulfur, and chlorine species [145] .
Oxidative post-translational modifications of proteins
The oxidation of cysteine and methionine residues within proteins occurs relatively readily. Cysteine residues within proteins are readily oxidized due the free thiol (-SH) group. Oxidation of the cysteine thiol group to cysteine sulfenic, sulfinic and sulfonic acid derivatives occurs in the presence of oxidants such as H 2 O 2 . The cysteine thiol group can also be oxidized, to form either an inter-or intra-molecular disulfide (RS-SR) with another free thiol. Similarly, a methionine residue can be oxidized to methionine sulfoxide [146] (Fig. 3) . Other oxidative modifications to amino acid residues include tryptophan oxidation to hydroxytryptophan and further to N-formylkynurenine or kynurenine [146] . Attack by
• OH results in the hydroxylation of phenylalanine, with the formation of o-tyrosine, m-tyrosine and 3,4-dihydroxyphenylalanine. The hydroxyl radical, along with other reactive species, induces the formation of the tyrosyl radical and tyrosine oxidation to 3,4-dihydroxyphenylalanine [147, 148] . The tyrosine radical can readily form dityrosine by reacting with another tyrosyl radical, forming stable inter-or intra-molecular cross-links. Chlorination of proteins, mediated by HOCl production catalyzed by MPO is another modification that occurs to proteins, potentially altering their function. Chlorination has been most widely reported at tyrosine residues, forming 3-chlorotyrosine. Chloramines on lysine and histidine residues constitute important intermediates in the formation of stable end-products of chlorination [149, 150] . It is this chlorination of proteins that is responsible for the antimicrobial effects of MPO-derived HOCl during the respiratory burst [151] . Protein carbonyls are formed through oxidative cleavage of protein backbones. Oxidative deamination of lysine and glutamic acid also results in protein carbonyls [152] . Since carbonyls can arise from different mechanisms, their concentration is commonly higher than that of other biomarkers [153] . Nitration of tyrosine and tryptophan residues in inflamed tissues has been extensively reported in the literature and modulates the structure and function of proteins in many disease states (Fig. 4) [154] [155] [156] . Under conditions of oxidative stress, chemical species such as peroxynitrite (ONOO − ) may be generated, which can result in nitration of tyrosine residues to form 3-nitrotyrosine [61, 157, 158] . Tyrosine nitration involves the replacement of the C3 hydrogen atom of the tyrosine aromatic ring with a nitro group (R-NO 2 ) [159] . This modification occurs within a polypeptide sequence (i.e. a tyrosine residue within a protein) or occurs to a free tyrosine amino acid. Nitration is usually a two-step process [160] , in which (i) tyrosine is oxidized resulting in a tyrosine radical and (ii) a radical-radical reaction occurs between the tyrosine radical and nitrogen dioxide (NO 2 ). One widely studied pathway for nitration is the production of the ROS/RNS peroxynitrite (ONOO¯). Peroxynitrite is formed by NO and Ο 2 ⋅− combining in a fast radical-radical reaction meaning that NO outcompetes the dismutation of Ο 2 ⋅− catalyzed by SOD [161] . A second pathway of 3-nitrotyrosine formation involves MPO [162, 163] . In the presence of H 2 O 2 and nitrite, MPO catalyzes the production of both the tyrosine radical and NO 2 [159] , as shown in Fig. 4 .
Generation of autoantibodies directed against post translationally modified protein antigens
When proteins are chemically modified (e.g. by oxidative modifications) the immune system may fail to recognize the protein as 'self' and mount an immune response against the newly created epitope . Such events may be associated with innate and adaptive immune system abnormalities, leading to the production of autoantibodies and cell-mediated autoimmunity. Thus, autoimmunity is characterized by a loss of tolerance to self-antigens and generation of autoantibodies against host macromolecules, such as DNA, nuclear proteins and even extracellular proteins. Subsequently, autoantibodies form immune complexes that are associated with inflammation and disease [166] . The increased oxidative stress in SLE contributes to immune system dysregulation, and the degree of chemical modifications of serum proteins shows striking correlations with disease activity and organ damage in this disease [167] . Antibodies recognizing 3-nitrotyrosine have been identified in the synovium of RA patients and the levels of such antibodies correlate with disease activity [158] . Nitrotyrosine is often described as a stable marker of oxidative/ nitrative stress in inflammatory diseases [168] . Autoantibodies directed against oxidized proteins have been demonstrated in SLE [169] .
Under normal circumstances, cells which have died by the process of apoptosis (programmed cell death) are engulfed by macrophages without inducing inflammation. A failure of inflammatory cells to undergo apoptosis has been implicated in the persistence of the inflammatory response [170] , while chronic exposure to oxidative stress is associated with resistance to apoptosis [171] . In SLE, the clearance of apoptotic cells by macrophages is impaired [172] , which may allow apoptotic cells to serve as a reservoir of autoantigens, these neoantigens possibly including oxidatively modified proteins. The uncleared apoptotic cells undergo secondary necrosis, a loss of membrane integrity and the spillage of intracellular proteins into the extracellular space for the induction of autoreactive T and B cells which drive the process of inflammation [173] .
Serum autoantibodies to carbamylated proteins
Protein citrullination is the result of an enzymatic post-translational modification of arginine residues, catalyzed by the enzyme peptidyl arginine deiminase (PAD) [174] , while carbamylation is a chemical reaction. Both citrullination and carbamylation exemplify that posttranslational modifications can give rise to an epitope which then instigates the generation of autoantibodies that are of clinical diagnostic importance. Anti-citrullinated protein antibodies (ACPA), first described by Schellekens et al. [175] , include antibodies such as anti-MCV (anti modified citrullinated vimentin) and play an important role in the diagnosis, prognosis and therapeutic approach to patients with RA [176] . Protein carbamylation results in the conversion of lysine to homocitrulline, and occurs ubiquitously in the presence of the reactive metabolite, cyanate. Anti-carbamylated protein antibodies (anti-CarP; also called anti-homocitrullinated protein antibodies -AHPA) are present in sera from RA patients and in an animal model of autoimmune arthritis [177] . In terms of the chemical structures, there are similarities between citrulline (produced by the PAD-catalyzed reaction) and homocitrulline, such that anti-citrullinated protein antibodies may also bind homocitrullinated antigens [178] . However, it appears that not all anti-CarP antibodies cross-react with citrullinated epitopes. Thus, it is possible that identification of cross-reactivity between citrullinated and carbamylated proteins has the potential to define subsets of RA patients [179] .
Serum autoantibodies to oxidized type II collagen and to the oxidized complement component, C1q
Evidence that post-translational modifications of protein structures are important in RA was provided by studies in which chemical modifications of type II collagen were shown to increase immunogenicity [180, 181] . Type II collagen is the predominant cartilage collagen. However anti-native type II collagen antibodies occur only in 3-27% of patients with RA [182] [183] [184] . As such, it has been difficult to substantiate the role of autoimmunity to type II collagen in the pathogenesis of RA. Significantly more RA patient antibodies recognized the modified forms of the protein than the unmodified form [180] . Modification of type II collagen by oxidants including
• OH, HOCl, ONOO − or glycation with ribose, increases the antigenicity of type II collagen and results in aggregation and/or cleavage of the molecule [180] . In addition, antibodies to HOCl-modified type II collagen are specific biomarkers of RA [185] . A greater proportion of early RA patients exhibited antibodies to HOCl-modified type II collagen (90%) compared to unmodified type II collagen (18%). The sensitivity and specificity of the binding of autoantibodies to ROS-modified type II collagen in early RA compared with healthy control individuals was 92% and 98%, respectively. Furthermore, the number of patients with antibodies to posttranslationally modified type II collagen was higher in patients who did Fig. 3 . Examples of the chemical structures of some of the post-translationally modified amino acid residues that have been observed within target proteins. ROS production can result in the oxidation of cysteine residues within proteins, oxidizing cysteine to sulfenic, sulfinic and sulfonic acid derivatives; methionine can be oxidized to methionine sulfoxide. Oxidation of phenylalanine residues leads to the formation of o-tyrosine and 3,4-dihydroxyphenylalanine. The tyrosine radical can readily form dityrosine, be nitrated to form nitrotyrosine, or undergo chlorination to form 3-chlorotyrosine.
not respond to disease-modifying anti-rheumatic drugs (DMARDs; e.g. methotrexate) compared to patients who responded to DMARDs [185] . Moreover, no anti-ROS-modified type II collagen reactivity was detected in other inflammatory diseases [180] nor in arthralgia patients that were ACPA positive but with no RA [185] . Thus, antibodies to posttranslationally modified type II collagen appear to be of great relevance in RA [186] . Autoimmunity to post-translationally modified type II collagen has been clearly demonstrated in relation to citrullinated type II collagen [187] and ROS-modified type II collagen [165, 180, 185] , although specific anti-carbamylated type II collagen remains to be demonstrated in human sera. Overall, the current findings support the possibility that chemical oxidative modifications of self-antigens, in RA in particular and in inflammation in general, may be the cause of the formation of neoepitopes leading to autoimmunity [164, 188, 189] . Another example of oxidative post-translational modifications giving rise to the breaking of immune tolerance is provided by the complement protein C1q, which contains a collagen-like domain. Antibodies to C1q are known to be clinically useful in the diagnosis of nephritis in SLE. Recently, it was demonstrated that the oxidative modification of C1q increased the antigenicity of C1q in an animal model [190] and when testing serum from SLE patients [191] (and reviewed in reference [164] ).
Conclusions
Targeted approaches using novel inhibitors of ROS-generating enzymes offer new hope for the treatment of autoimmune diseases. Some of the most promising future strategies for redox-based therapeutic compounds are the activation of endogenous cellular antioxidant systems (e.g. Nrf2-dependent pathways), inhibition of disease-relevant sources of ROS/RNS (e.g. isoform-specific NOX inhibitors), or perhaps the specific scavenging of disease-triggering ROS/RNS via site-specific antioxidants. MPO inhibitors have been shown to ameliorate arthritis in animal models [45, 192] .
Oxidative stress leads to the formation of oxidative post translational modifications which, in autoimmune disease, cause the formation of neoepitopes and gives rise to autoantibodies. The analysis of autoantibodies directed against oxidatively modified protein antigens, such as carbamylated proteins and type II collagen, might become a means for therapeutic monitoring and outcome prediction. The chemical modification of type II collagen induces or worsens experimental arthritis, so it is possible that blocking this post-translational modification could ameliorate arthritis [193, 194] . A combination of multiple oxidative protein damage markers, within large-scale panels and together with pattern analysis, could provide an additional approach to measuring disease progression or therapeutic outcome. Antibodies to post-translationally modified antigens could conceivably identify clinically-relevant sub-populations of patients such as patients who are likely to respond to different medications [9] .
